| JYSB2000423 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2020-08-31 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Filed | 2020-09-11 | view |
| JYSB2000422 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2020-08-31 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Filed | 2020-09-11 | view |
| JYSB2000287 | 依达赛珠单抗注射液 | idarucizumab | Injection | Biological Products | Supplementary Application | 2020-06-19 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Filed | 2020-06-22 | view |
| JYSB2000191 | BI655130注射液 | spesolimab | Injection | Biological Products | Supplementary Application | 2020-05-23 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | In Review | 2020-05-22 | view |
| JYSB1900280 | 依达赛珠单抗注射液 | idarucizumab | Injection | Biological Products | Supplementary Application | 2019-10-16 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2020-09-27 | view |
| JYSB1800276 | 依达赛珠单抗注射液 | idarucizumab | Injection | Biological Products | Supplementary Application | 2018-12-06 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Filed | 2018-12-13 | view |
| JYSB1800205 | 依达赛珠单抗注射液 | idarucizumab | Injection | Biological Products | Supplementary Application | 2018-09-25 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Filed | 2018-09-28 | view |
| JYHZ2000172 | 噻托溴铵喷雾剂 | tiotropium bromide | Spray | Chemical Drugs | License Renew | 2020-06-28 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2020-12-11 | view |
| JYHZ2000171 | 噻托溴铵喷雾剂 | tiotropium bromide | Spray | Chemical Drugs | License Renew | 2020-07-04 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2020-12-11 | view |
| JYHZ1900154 | 美洛昔康片 | meloxicam | Tablet | Chemical Drugs | License Renew | 2019-06-10 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2020-04-02 | view |
| JYHZ1900151 | 美洛昔康片 | meloxicam | Tablet | Chemical Drugs | License Renew | 2019-06-10 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2020-04-02 | view |
| JYHZ1900081 | 噻托溴铵粉吸入剂 | tiotropium bromide | Powder for inhalation | Chemical Drugs | License Renew | 2019-03-25 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2019-08-16 | view |
| JYHZ1900080 | 噻托溴铵粉吸入剂 | tiotropium bromide | Powder for inhalation | Chemical Drugs | License Renew | 2019-04-03 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2019-08-16 | view |
| JYHZ1700322 | 异丙托溴铵吸入气雾剂 | ipratropium bromide | Aerosol | Chemical Drugs | License Renew | 2017-10-23 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2018-07-04 | view |
| JYHZ1700321 | 异丙托溴铵吸入气雾剂 | ipratropium bromide | Aerosol | Chemical Drugs | License Renew | 2017-10-31 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2018-07-04 | view |
| JYHZ1700174 | 丁溴东莨菪碱片 | scopolamine butylbromide | Tablet | Chemical Drugs | License Renew | 2017-11-18 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Promeco SADe CV | Certificate Issued | 2018-06-20 | view |
| JYHZ1700173 | 丁溴东莨菪碱片 | scopolamine butylbromide | Tablet | Chemical Drugs | License Renew | 2017-11-18 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Promeco SADe CV | Certificate Issued | 2018-06-20 | view |
| JYHZ1700172 | 丁溴东莨菪碱片 | scopolamine butylbromide | Tablet | Chemical Drugs | License Renew | 2017-11-18 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Promeco SADe CV | Certificate Issued | 2018-06-20 | view |
| JYHZ1700171 | 丁溴东莨菪碱片 | scopolamine butylbromide | Tablet | Chemical Drugs | License Renew | 2017-11-18 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Promeco SADe CV | Certificate Issued | 2018-06-20 | view |
| JYHZ1700069 | 利格列汀片 | linagliptin | Tablet | Chemical Drugs | License Renew | 2017-08-03 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;West-Ward Columbus Inc | Certificate Issued | 2017-09-26 | view |
